 |
|
Anticoagulants and acute kidney injury: clinical and pathology considerations
Sergey V. Brodsky
Kidney Res Clin Pract. 2014;33(4):174-180. Published online 2014 Nov 18 DOI: https://doi.org/10.1016/j.krcp.2014.11.001
|
|
Citations to this article as recorded by
 A comprehensive survey of warfarin-induced hepatic toxicity using histopathological, biomarker, and molecular evaluation
Mona M. Atia, Heba Allah Ahmed Mahmoud, Magdy Wilson, Elham A. Abd-Allah
Heliyon.2024; 10(4): e26484. CrossRef RecQ dysfunction contributes to social and depressive-like behavior and affects aldolase activity in mice
Yujun Hou, Jae-Hyeon Park, Xiuli Dan, Xixia Chu, Beimeng Yang, Mansoor Hussain, Deborah L. Croteau, Vilhelm A. Bohr
Neurobiology of Disease.2023; 180: 106092. CrossRef Anticoagulant-related nephropathy induced by direct-acting oral anticoagulants: Clinical characteristics, treatments and outcomes
Shanshan Chen, Dehua Liao, Minghua Yang, Shengfeng Wang
Thrombosis Research.2023; 222: 20. CrossRef Prevalence of Atrial Fibrillation in Patients With end Stage Renal Disease
Maria da Graça Lepre Hawerroth, Lucas Yuji Sonoda, Jean José Silva, Walter Alvarenga de Oliveira
International Journal of Cardiovascular Sciences.2023;[Epub] CrossRef Currently Used Methods to Evaluate the Efficacy of Therapeutic Drugs and Kidney Safety
Hung-Jin Huang, Chu-Lin Chou, Tin Sandar, Wen-Chih Liu, Hsiu-Chien Yang, Yen-Chung Lin, Cai-Mei Zheng, Hui-Wen Chiu
Biomolecules.2023; 13(11): 1581. CrossRef Lessons for the clinical nephrologist: acute kidney injury during therapy with apixaban
Gisella Vischini, Serena Speciale, Agnieszka Przygocka, Laura Martano, Gaetano La Manna, Olga Baraldi
Journal of Nephrology.2023; 37(2): 511. CrossRef IgA Nephropathy Is the Most Common Underlying Disease in Patients With Anticoagulant-Related Nephropathy
Hernando Trujillo, Justo Sandino, Teresa Cavero, Fernando Caravaca-Fontán, Eduardo Gutiérrez, Ángel M. Sevillano, Amir Shabaka, Gema Fernández-Juárez, Pablo Rodríguez Doyágüez, Rocío Gimena Muñoz, Leonardo Calle García, Virginia Cabello, José Manuel Muñoz
Kidney International Reports.2022; 7(4): 831. CrossRef Dabigatran-Induced Nephropathy and Gastrointestinal Bleeding and Its Successful Treatment with Idarucizumab: A Case Report
Francesca Marchesini, Andrea Ossato, Alberto Zendrini, Federica Arginelli, Teresa Zuppini, Nicola Realdon, Massimo Zamperini, Roberto Tessari
Hospital Pharmacy.2022; 57(2): 241. CrossRef Acute Kidney Injury in Patients with Non-Valvular Atrial Fibrillation Treated with Rivaroxaban or Warfarin: A Population-Based Study from the United Kingdom
Antonio González-Pérez, Yanina Balabanova, María E Sáez, Gunnar Brobert, Luis A García Rodríguez
Clinical Epidemiology.2022; Volume 14: 1281. CrossRef Simultaneous subacute interstitial nephritis and anticoagulant-related nephropathy related to novel oral anticoagulants use
Zhen-Ling Deng, Wen-Ling Yang, Xin-Yue Zhao, Zi-Yong Tang, Dan-Xia Zheng, Yue Wang
Renal Failure.2022; 44(1): 30. CrossRef The Rise and Fall of Antithrombin Supplementation in Cardiac Surgery
Marco Ranucci, Ekaterina Baryshnikova, Valeria Pistuddi, Umberto Di Dedda
Anesthesia & Analgesia.2022;[Epub] CrossRef Drug-Related Problems and Factors Involved in the Imbalance of Oral Anticoagulants in Lebanese Patients: A Cross-Sectional Study
Soukeina Bassam, Sara Mansour, Roula Ajrouche, Hawraa Kisserwan, Maya EL-Hajj, Salam Zein, Zahraa Dirani, Amal Al-Hajje
Dr. Sulaiman Al Habib Medical Journal.2022; 4(2): 77. CrossRef The impact on renal function after long-term use of anticoagulants in atrial fibrillation patients
Wei-Chieh Lee, Pai-Wei Lee, Po-Jui Wu, Yen-Nan Fang, Huang-Chung Chen, Yu-Sheng Lin, Hsiu-Yu Fang, Shang-Hung Chang, Ping-Yen Liu, Mien-Cheng Chen
Thrombosis Journal.2021;[Epub] CrossRef Management of Anticoagulant-Related Nephropathy: A Single Center Experience
Tanja Belčič Mikič, Nika Kojc, Maja Frelih, Andreja Aleš-Rigler, Željka Večerić-Haler
Journal of Clinical Medicine.2021; 10(4): 796. CrossRef Complications and mortality in patients with chronic kidney disease undergoing total shoulder arthroplasty
Andrew M. Schwartz, Albert T. Anastasio, Kevin X. Farley, Susanne Boden, Eric R. Wagner, Michael B. Gottschalk
Seminars in Arthroplasty: JSES.2020; 30(2): 96. CrossRef Anticoagulant-related nephropathy: A case report
KeeTat Lee, WanSyahira Wan A Kammal, BoonHuei Kong
Saudi Journal of Kidney Diseases and Transplantation.2020; 31(6): 1403. CrossRef Acute Renal Failure in a Patient with Rivaroxaban-Induced Hypersensitivity Syndrome: A Case Report with a Review of the Literature and of Pharmacovigilance Registries
Gisela Marcelino, Ould Maouloud Hemett, Eric Descombes
Case Reports in Nephrology.2020; 2020: 1. CrossRef Drug-induced tubulointerstitial nephritis: hypersensitivity and necroinflammatory pathways
Allison A. Eddy
Pediatric Nephrology.2020; 35(4): 547. CrossRef Anticoagulant-related nephropathy: systematic review and meta-analysis
Karolinny Borinelli de Aquino Moura, Paula Marques Prates Behrens, Rafaela Pirolli, Aimee Sauer, Dayana Melamed, Francisco Veríssimo Veronese, André Luis Ferreira Azeredo da Silva
Clinical Kidney Journal.2019; 12(3): 400. CrossRef Kidney-based in vitro models for drug-induced toxicity testing
João Faria, Sabbir Ahmed, Karin G. F. Gerritsen, Silvia M. Mihaila, Rosalinde Masereeuw
Archives of Toxicology.2019; 93(12): 3397. CrossRef Direct oral anticoagulant and AKI: apixaban-induced acute interstitial nephritis
Christina DiMaria, Wael Hanna, Julie Murone, James Reichart
BMJ Case Reports.2019; 12(6): e230371. CrossRef Republished: Direct oral anticoagulant and AKI: apixaban-induced acute interstitial nephritis
Christina DiMaria, Wael Hanna, Julie Murone, James Reichart
Drug and Therapeutics Bulletin.2019; 57(11): 173. CrossRef Oral Anticoagulation in Patients With End-Stage Kidney Disease on Dialysis and Atrial Fibrillation
Austin Hu, Jingbo Niu, Wolfgang C. Winkelmayer
Seminars in Nephrology.2018; 38(6): 618. CrossRef Defining Minimum Necessary Anticoagulation-Related Communication at Discharge: Consensus of the Care Transitions Task Force of the New York State Anticoagulation Coalition
Darren Triller, Anne Myrka, John Gassler, Kelly Rudd, Patrick Meek, Peter Kouides, Allison E. Burnett, Alex C. Spyropoulos, Jack Ansell
The Joint Commission Journal on Quality and Patient Safety.2018; 44(11): 630. CrossRef Deconstructing the Pharmacovigilance Hype Cycle
Manfred Hauben, Robert Reynolds, Patrick Caubel
Clinical Therapeutics.2018; 40(12): 1981. CrossRef Warfarin-related nephropathy with acute kidney injury in a patient with immunoglobulin A nephropathy
Hiroki Ishii, Keiji Hirai, Katsunori Yanai, Taisuke Kitano, Mitsutoshi Shindo, Haruhisa Miyazawa, Kiyonori Ito, Yuichiro Ueda, Yoshio Kaku, Taro Hoshino, Honami Mori, Susumu Ookawara, Yoshihiko Ueda, Yoshiyuki Morishita
CEN Case Reports.2018; 7(2): 198. CrossRef Acenocoumarol as an alternative anticoagulant in a patient with warfarin‐related nephropathy
Sapan Kumar Behera, Alphienes Stanley Xavier, Sandhiya Selvarajan, Hemachandren Munuswamy, Satish Haridasan, Bheemanathi Hanuman Srinivas
British Journal of Clinical Pharmacology.2018; 84(5): 1068. CrossRef Metformin prevents the development of severe chronic kidney disease and its associated mineral and bone disorder
Ellen Neven, Benjamin Vervaet, Kerstin Brand, Ulrike Gottwald-Hostalek, Britt Opdebeeck, Annelies De Maré, Anja Verhulst, Jean-Daniel Lalau, Said Kamel, Marc E. De Broe, Patrick C. D’Haese
Kidney International.2018; 94(1): 102. CrossRef Novel oral anticoagulant and kidney injury: apixaban-related acute interstitial nephritis
Basma Abdulhadi, Ramzi Mulki, Abhinav Goyal, Janani Rangaswami
BMJ Case Reports.2017; : bcr-2017-221641. CrossRef Néphropathie tubulaire secondaire à un surdosage en Warfarine
R. Bouvet, P.H. Bonnot, B. Bach, S. Boudjeltia, C. Sgro, L. Martin, J.M. Rebibou
La Revue de Médecine Interne.2017; 38: A227. CrossRef Atrial fibrillation in chronic kidney disease
Luminita Voroneanu, Alberto Ortiz, Ionut Nistor, Adrian Covic
European Journal of Internal Medicine.2016; 33: 3. CrossRef Oral Anticoagulants and Risk of Nephropathy
Vinay Narasimha Krishna, David G. Warnock, Nakshatra Saxena, Dana V. Rizk
Drug Safety.2015; 38(6): 527. CrossRef
|